SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001683168-23-006602
Filing Date
2023-09-21
Accepted
2023-09-21 17:04:07
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3/A pharmacyte_s3a3.htm   iXBRL S-3/A 225574
2 CONSENT pharmacyte_ex2301.htm EX-23.1 2176
  Complete submission text file 0001683168-23-006602.txt   430302

Data Files

Seq Description Document Type Size
3 XBRL PRESENTATION FILE pmcb-20230921_pre.xml EX-101.PRE 22721
4 XBRL LABEL FILE pmcb-20230921_lab.xml EX-101.LAB 34767
5 XBRL SCHEMA FILE pmcb-20230921.xsd EX-101.SCH 3021
7 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_s3a3_htm.xml XML 2847
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: S-3/A | Act: 33 | File No.: 333-272569 | Film No.: 231269699
SIC: 2836 Biological Products, (No Diagnostic Substances)